Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.

Clinical lung cancer - 1 Mar 2016

Myall Nathaniel J, Neal Joel W, Cho-Phan Cheryl D, Zhou Lisa Y, Stehr Henning, Zhou Li, Diehn Maximilian, Wakelee Heather A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Erlotinib Hydrochloride
Share to Indoles
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Proto-Oncogene Proteins B-raf

Share to Sulfonamides

Share to Vemurafenib

Source

Identifiers

PMID: 26776917
DOI: 10.1016/j.cllc.2015.12.001

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.PMID 26776917Read ↗

10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient.Semantic proximity Read ↗

Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation.Semantic proximity Read ↗

Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations.Semantic proximity Read ↗

Long-term survival in a patient with advanced non-smoking lung adenocarcinoma and no EGFR mutation after comprehensive therapy with EGFR-TKI-based therapy: A case report.Semantic proximity Read ↗

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.Semantic proximity Read ↗

A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.Semantic proximity Read ↗

Elderly former smoker with HRAS mutant non-small-cell lung cancer.Semantic proximity Read ↗

Ras oncogene mutations and survival in patients with lung cancer.Semantic proximity Read ↗

A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations.Semantic proximity Read ↗

Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?Semantic proximity Read ↗

Long-term response to gefitinib and crizotinib in lung adenocarcinoma harboring both epidermal growth factor receptor mutation and EML4-ALK fusion gene.Semantic proximity Read ↗

Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.